Summary

Eligibility
for people ages 18-99 (full criteria)
Healthy Volunteers
healthy people welcome
Dates
study started
estimated completion
Principal Investigator
by Urmimala Sarkar, MD, MPH
Photo of Urmimala Sarkar
Urmimala Sarkar

Description

Summary

Anticoagulants are a leading cause of acute injury from adverse drug events, leading to ~20,000 serious injuries reported to the Food and Drug Administration per year and more than 220,000 emergency department visits annually. Therefore, we propose to implement a health information technology (HIT) population management tool at two distinct anticoagulation clinics that will allow the care team to assign and track tasks essential for timely patient monitoring. We will examine its effect on anticoagulation management outcomes through a randomized trial, hypothesizing that such interventions can be effective as well as cost-effective strategies to improve patient safety in the context of anticoagulation management services.

Official Title

AntiCoagulation Tracking InterVention and Evaluation: Using a Customized Panel Management Platform to Improve Outcomes for Patients on Anticoagulation

Keywords

Anticoagulation Atrial Fibrillation Atrial Flutter Pulmonary Embolus/Emboli Deep Vein Thrombosis Stroke Hypercoagulability Pulmonary Embolism Thrombosis Venous Thrombosis Embolism Thrombophilia Panel Management for Anticoagulation Therapy

Eligibility

You can join if…

Open to people ages 18-99

  • Adults (age ≥18 years)
  • those prescribed an anticoagulation medication at Zuckerberg San Francisco General Hospital or University of California, San Francisco Health

You CAN'T join if...

  • Minors (age<18)
  • those not prescribed anticoagulation medication at ZSFG or UCSF Health

Lead Scientist at UCSF

  • Urmimala Sarkar, MD, MPH
    Urmimala Sarkar MD, MPH is Professor of Medicine at UCSF in the Division of General Internal Medicine, Associate Chair for Faculty Experience for the Department of Medicine, Associate Director of the UCSF Center for Vulnerable Populations, and a primary care physician at Zuckerberg San Francisco General Hospital’s Richard H. Fine People's Clinic.

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT04059965
Study Type
Interventional
Last Updated